Mutant reverse transcriptase
US9580698B1 · kind B1 · utility
47Cited by
1References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 23, 2016 |
| Grant date | Feb 28, 2017 |
| Priority date | — |
| Expiry date | Sep 23, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Y301/26004
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
A mutant MMLV reverse transcriptase that may have an improvement in one or more properties is provided. For example, the present reverse transcriptase is believed to be more efficient relative to other commercially available MMLV reverse transcriptase variants, particularly for templates with a higher GC content.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.